334 related articles for article (PubMed ID: 3781466)
1. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
2. [MTX resistant mechanisms in human choriocarcinoma cells].
Sakai K; Fujino T; Hoshi S; Shinkai N; Hashimoto M; Yasuda T; Kato H; Yamada H; Wake N; Ichinoe K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):807-14. PubMed ID: 3474305
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-resistant mechanisms in human choriocarcinoma cells.
Sakai K; Wake N; Fujino T; Yasuda T; Kato H; Fujimoto S; Fujinaga K
Gynecol Oncol; 1989 Jul; 34(1):7-11. PubMed ID: 2737530
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of resistance to antifolates, a review.
Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
Bürkle A; Heilbronn R; zur Hausen H
Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
[TBL] [Abstract][Full Text] [Related]
8. Genetic changes in methotrexate-resistant mosquito cells.
Shotkoski FA; Fallon AM
Arch Insect Biochem Physiol; 1990; 15(2):79-92. PubMed ID: 1724612
[TBL] [Abstract][Full Text] [Related]
9. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
[TBL] [Abstract][Full Text] [Related]
10. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
11. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
Affleck JG; Nowickyj SM; Walker VK
Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
[TBL] [Abstract][Full Text] [Related]
12. Development of methotrexate-resistant human choriocarcinoma cells in culture.
Sekiya S; Kaiho T; Takamizawa H
Gynecol Oncol; 1985 May; 21(1):46-53. PubMed ID: 4039287
[TBL] [Abstract][Full Text] [Related]
13. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
Domin BA; Grill SP; Bastow KF; Cheng YC
Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
[TBL] [Abstract][Full Text] [Related]
14. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
Miyachi H; Jiao L; Sowers LC; Scanlon KJ
In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
[TBL] [Abstract][Full Text] [Related]
15. Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line.
Han B; Xiang Y; Wang Y; Wang Z; Zhang H; Huang S
Int J Gynecol Cancer; 2010 Oct; 20(7):1259-63. PubMed ID: 21495249
[TBL] [Abstract][Full Text] [Related]
16. [Methotrexate and its drug resistance].
Nagura E
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237
[TBL] [Abstract][Full Text] [Related]
17. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
19. Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).
Rosowsky A; Wright JE; Cucchi CA; Flatow JL; Trites DH; Teicher BA; Frei E
Cancer Res; 1987 Nov; 47(22):5913-8. PubMed ID: 3664492
[TBL] [Abstract][Full Text] [Related]
20. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
Ohnuma T; Lo RJ; Scanlon KJ; Kamen BA; Ohnoshi T; Wolman SR; Holland JF
Cancer Res; 1985 Apr; 45(4):1815-22. PubMed ID: 3856477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]